top of page
  • Writer's pictureFNBC

WVU believes new technology could help detect signs of overdose

The West Virginia University Rockefeller Neuroscience Institute (RNI) is working on technology that can remotely detect and monitor vital signs. This new technology has the potential to assist in the early detection of drug overdoses. The technology being developed by RNI is called the Celero Virtual Mount. It is a small device that can be ingested like a pill and uses built-in sensors to collect vital sign data. The data is then transmitted wirelessly to a remote location, where it can be analyzed by medical professionals. One of the primary goals of this technology is to address the ongoing opioid crisis in the United States. According to the Centers for Disease Control and Prevention, West Virginia has the highest rate of drug overdose deaths in the country. Being able to remotely monitor vital signs could help in the early detection of an overdose and potentially save lives. Dr. Ali Rezai, the executive chair of RNI, explains that the Celero Virtual Mount has the potential to revolutionize patient care. He states, "By remotely tracking a patient's vitals, we can identify signs of distress or overdose much faster than waiting for the patient to exhibit visible symptoms." In addition to its application in overdose detection, the Celero Virtual Mount has a range of other potential uses. It can be used to monitor patients with chronic conditions, such as heart disease or diabetes, from the comfort of their own homes. This would allow for more personalized and efficient healthcare. The device is also being studied for its potential use in assessing concussions. Traumatic brain injuries are a significant concern in sports and other high-impact activities. By monitoring a patient's vital signs remotely, medical professionals can better assess the severity of a concussion and determine appropriate treatment. The Celero Virtual Mount is still in the development stage, but RNI is optimistic about its potential impact. They are currently conducting clinical trials to ensure the device's safety and effectiveness. If successful, it could receive FDA approval and become widely available in the near future. One of the challenges in developing this technology is ensuring its privacy and security. Transmitting sensitive medical data wirelessly raises concerns about data breaches and unauthorized access. RNI is taking steps to address these concerns by implementing robust encryption measures and partnering with cybersecurity experts. The development of remote monitoring technology is an exciting advancement in healthcare. It has the potential to improve patient outcomes, reduce healthcare costs, and increase access to care, particularly in rural or underserved areas. The Celero Virtual Mount represents a significant step forward in this field and could pave the way for other innovative healthcare solutions. The work being done by RNI is an excellent example of the potential of technology to address real-world challenges. By combining medical expertise with cutting-edge technology, they are pushing the boundaries of what is possible in healthcare. Their dedication to finding solutions to critical issues, such as the opioid crisis, is commendable. As the development of the Celero Virtual Mount continues, it will be interesting to see how it evolves and how it is embraced by the medical community. If successful, it could revolutionize the way vital signs are monitored and contribute to a more proactive and personalized approach to healthcare. With the opioid crisis still ongoing and chronic conditions on the rise, technologies like this could not come soon enough.

0 views0 comments

Recent Posts

See All

Amazon founder Jeff Bezos sells shares worth over $4bn

Amazon founder Jeff Bezos has sold shares worth over $4 billion. The multi-billionaire made this move after relocating to Miami last year, where there is no tax on share sales above $250,000. Bezos,

bottom of page